SmithMidland Corporation SMID Reports Q4 2023 In Line Steady Performance Continues Wall Street Ends Lower as Inflation Fears Drive Bond Yields Higher Acumen Pharmaceuticals ABOS Gains Momentum Support Holds at 237 Resistance at 261 in Focus GRI Bio GRI Stock Today Unchanged at 219 Key Levels 20260521